Recent advances in the stabilization of monomeric stibinidene chalcogenides and stibine chalcogenides
Dalton Transactions · 2024 · 53 (20) · 8524-8534
DOI: 10.1039/d4dt00506f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dalton Transactions, 2024. Verfasst von John S Wenger und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA. johnstone@ucsc.edu. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Division of Chemistry, American Chemical Society Petroleum Research Fund, Arnold and Mabel Beckman Foundation.
Abstract (Originalsprache)
The synthetic strategies employed to isolate monomeric stibinidene chalcogenides (RSbCh) and monomeric stibine chalcogenides (R 3 SbCh) are discussed, and a perspective on the outcomes and future directions of this exciting area is provided.
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA. johnstone@ucsc.edu.
Förderung
- Division of Chemistry
- American Chemical Society Petroleum Research Fund
- Arnold and Mabel Beckman Foundation
Zitieren
APA
Wenger, J. S., & Johnstone, T. C. (2024). Recent advances in the stabilization of monomeric stibinidene chalcogenides and stibine chalcogenides. Dalton Transactions, 53(20), 8524-8534. https://doi.org/10.1039/d4dt00506f
Vancouver
Wenger JS, Johnstone TC. Recent advances in the stabilization of monomeric stibinidene chalcogenides and stibine chalcogenides. Dalton Transactions. 2024;53(20):8524-8534. doi:10.1039/d4dt00506f
BibTeX
@article{Wenger2024,
author = {Wenger, John S and Johnstone, Timothy C},
title = {Recent advances in the stabilization of monomeric stibinidene chalcogenides and stibine chalcogenides},
journal = {Dalton Transactions},
year = {2024},
volume = {53},
number = {20},
pages = {8524--8534},
doi = {10.1039/d4dt00506f}
}
EUVIMED